Read Our Latest Analysis on Gilead Sciences Gilead Sciences Trading Down 1.8 % NASDAQ GILD opened at $104.08 on Friday. The stock’s 50-day simple moving average is $93.87 and its two-hundred day ...

Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Equities researchers at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Gilead Sciences in a report issued on ...

Maxim Group analyst Michael Okunewitch maintained a Hold rating on Gilead Sciences (GILD – Research Report) today. The company’s shares closed yesterday at $105.96. Leverage the power of ...

Looking at the universe of stocks we cover at Dividend Channel, in trading on Friday, shares of Gilead Sciences Inc (Symbol: GILD) were yielding above the 3% mark based on its quarterly dividend ...

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

FOSTER CITY, Calif., February 11, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 2.6% in the company’s quarterly ...

Alan Carr had Amanda Holden in fits as he fell off a kayak into the sea while trying to relieve himself over the side. The comedian slipped overboard as he and Holden were filming Amanda & Alan’s ...

Gilead Sciences has shored up its antibody-drug conjugate pipeline by licensing a candidate from German biotech Tubulis in a deal worth up to $415 million. The agreement includes an upfront ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Secret Genius will see Alan Carr and Susie Dent test Britain’s brainpower like never before to uncover the country’s most gifted and unsung minds. Produced by Mothership TV and GroupM Motion ...

Gilead Sciences has taken a major step towards increasing global access to HIV prevention with the signing of royalty-free voluntary licensing agreements with six generic manufacturers ...